Navigation Links
Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
Date:2/1/2011

d quarter results were in line with our expectations, the issues of high unemployment and a challenging health insurance environment continue to impact our industry.  However, the inventory reduction efforts by some of our larger customers are subsiding, as we are beginning to experience an increase in orders which should improve our results for the balance of the fiscal year," commented Joe Kaufmann, President and CEO of the Company.  "We expect our sports medicine and spine product sales will increase by approximately 30% and 50% sequentially in our third quarter.  Overall, sales of our biomaterials products are expected to increase by an amount in the range of 8% to 10% sequentially in our third quarter despite an anticipated decline in cardiology collagen sales to St. Jude Medical of approximately 25%.  Furthermore, we are optimistic that our fourth quarter will continue to show growth in our biomaterial business due to the ongoing expansion of the ECM products distributed by our strategic partner, Synthes, as well as an improvement in the overall business climate."

Supplemental Sales Data.  Details of the Company's net sales for the three and six months ended December 31, 2010 and 2009 are summarized below.  Three Months Ended
December 31,Year over
Year %
ChangeSix Months Ended
December 31,Year over
Year %
Change($ millions)2010200920102009Biomaterials Products  Orthopaedic ProductsSports Medicine Products

$2.6

$3.1

(14%)

$5.3

$6.7

(20%)Spine Products

2.0

2.8

(30%)

4.5

5.6

(19%)Other Orthopaedic Products

0.2

0.1

34%

0.3

0.2

23%   Total Orthopaedic Products

$4.8

$6.0

(20%)

$10.1

$12.5

(19%)   Cardiovascular Products

4.1

4.3

(5%)

8.4

9.3


'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
2. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
3. Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
4. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
5. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
10. Pharmos Corporation Reports 2008 Second Quarter Results
11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... The report “Adipic Acid Market by Application, ... Trends & Forecast to 2019” report analyzes the ... opportunities, and trends in different regions. , Browse ... through 217 slides and in-depth TOC on “Adipic ... 2019”., http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html , Early buyers will receive ...
(Date:10/25/2014)... ViaDerma, Inc (OTCQB: ... to bringing new products to market, is committed ... has developed an innovative, patent-pending dual carrier transdermal ... of pharmaceutical active ingredients to penetrate the skin ... therapy. The transdermal delivery method also overcomes microbial ...
(Date:10/25/2014)... York, NY (PRWEB) October 23, 2014 ... announced the winners for the 2014 BioProcess International ... business strategies, social corporate responsibility and technology applications ... more effective treatments to a global patient base. ... by their peers during a very entertaining and ...
(Date:10/25/2014)... According to new market research report ... (Colocation, Enterprise, Telecom), by Design Types (Electrical, Mechanical), ... Tier 3, Tier 4) - Global Forecast to ... Data Center Construction Market into various segments with ... research report also identifies the factors driving this ...
Breaking Biology Technology:Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 2Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 3Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 4ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 2Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 4
... ANNAPOLIS, Md. , Jan. 26 The following ... CEO of PharmAthene, regarding the Commission on the Prevention of ... Today,s Report Card by the Commission on the Prevention of ... warning that America still remains vulnerable to bioterrorism.  Our Nation,s ...
... , SHANGHAI , ... pharmaceutical R&D outsourcing Service Company in China , announced,that ... visited Sundia on January 22, 2010 . M.Raffarin, ... Serge,Feneuille and Mr. Erwan Davoux of ...
... , , , , ... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ("3SBio" or "the Company"), ... and marketing,biopharmaceutical products, today announced that it will release financial,results for ... 8:00 PM (Eastern) on, Thursday, February 11, 2010 . , ...
Cached Biology Technology:Former French Prime Minister Jean-Pierre Raffarin Visits Sundia 23SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010 2
(Date:10/25/2014)... Oct.  22, 2014   MedNet Solutions , a ... management systems, is pleased to announce the 2014 ... – to be held in Bloomington, Minnesota ... to have record attendance and promises to be informative, ... The focus of the meeting is iMedNet™ ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 This ... is a relatively new space in heavy pursuit of ... are unique to miRNAs compared to other RNA components. ... make it a novel candidate for use as a ... pursuit of miRNA-based microarrays and diagnostics for the advancement ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 A ... in-depth analysis of the current and future genetic testing ... principles and types are covered in this report. On ... market trends; drivers; and existing strengths and challenges; forecast ... the market is likely to grow at a CAGR ...
Breaking Biology News(10 mins):MedNet Solutions To Host Third Annual iMedNet User Group Meeting 2MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Genetic Testing Market Outlook 2018 2
... pain more than men despite the popular notion that the ... differences in pain have found that not only do women ... also experience it in more bodily areas, more often and ... seem to be differences in how men and women think ...
... base are the guinea pigs for Oak Ridge National ... better determine whether a species has vanished. , After ... biologists were a bit concerned and were looking for ... ecologist and member of ORNL's Environmental Sciences Division. A ...
... a newly released method to analyze functional magnetic ... that the interconnections between different parts of the ... other findings answer longstanding debates about how brain ... are presented in the current (June 1) issue ...
Cached Biology News:Women feel more pain than men, research shows 2Women feel more pain than men, research shows 3Elusive salamanders have role in developing new sampling models 2Elusive salamanders have role in developing new sampling models 3Brain networks change according to cognitive task 2Brain networks change according to cognitive task 3